Impact of Aging on Currently Employed Animal Models of Disease and Chronic Conditions: Demonstration Projects (UH2/UH3)

The summary for the Impact of Aging on Currently Employed Animal Models of Disease and Chronic Conditions: Demonstration Projects (UH2/UH3) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Impact of Aging on Currently Employed Animal Models of Disease and Chronic Conditions: Demonstration Projects (UH2/UH3): The goal of this FOA is to test whether or not the ages of laboratory animals is an important consideration in experimental outcomes in the study of disease pathology, degenerative condition, response to therapy, intervention or environmental exposure. The majority of studies of human conditions and diseases in laboratory animals are done using young animals. Young animals may be appropriate for study of human diseases that are prevalent in young humans. However, older animals may be more appropriate for study of human diseases that are prevalent in older humans. While this is a testable hypothesis, there have been obstacles to performing such studies: they are more costly and take more time than studies with young animals. Nevertheless, studies in older animals may be critical to advancing basic research and translational studies from animal models to human populations where aging is itself known to impact the condition, disease or response. To test this assumption, this FOA will provide funds for demonstration projects to address two questions: 1. Does the age of the model organism influence experimental outcomes? 2. Are older animals better models of experimental studies for conditions, interventions, diseases or exposures for which aging is a risk factor of the human condition (for which the model was developed)?

Federal Grant Title:	Impact of Aging on Currently Employed Animal Models of Disease and Chronic Conditions: Demonstration Projects (UH2/UH3)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Environment Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-AG-16-020
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.113, 93.121, 93.853, 93.855, 93.856, 93.866
CFDA Descriptions:	Environmental Health; Oral Diseases and Disorders Research; Extramural Research Programs in the Neurosciences and Neurological Disorders; Allergy and Infectious Diseases Research; Microbiology and Infectious Diseases Research; Aging Research
Current Application Deadline:	Jan 6, 2016
Original Application Deadline:	Jan 6, 2016
Posted Date:	Nov 2, 2015
Creation Date:	Nov 2, 2015
Archive Date:	Feb 6, 2016
Total Program Funding:	$2,100,000
Maximum Federal Grant Award:	none
Minimum Federal Grant Award:	none
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Native American tribal governments (Federally recognized)
Native American tribal organizations (other than Federally recognized tribal governments)
County governments
Public housing authorities/Indian housing authorities
City or township governments
Private institutions of higher education
Public and State controlled institutions of higher education
Special district governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
For profit organizations other than small businesses
Small businesses
State governments
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-16-020.html
Grant Announcement Contact: NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

National Institutes of Health 301-496-3405
Similar Government Grants: • Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Tri...; • Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clini...; • Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Basic ...; • Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clini...; • Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed); • Outstanding New Environmental Scientist Award (ONES); • Environmental Health Sciences Core Center Grants; • Leiomyomata Uteri: Basic Science and Translational Research
More Grants from the National Institutes of Health: • The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Preven...; • Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional); • Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Tri...; • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...